Our global portfolio has more than 1,400 molecules across a broad range of therapeutic areas spanning noncommunicable and infectious diseases.

Our diverse portfolio delivers trusted, quality medicines that treat nine out of ten of the World Health Organization’s (WHO) leading causes of death and more than 200 of our medicines are on the WHO Essential Medicines List.

We have a broad portfolio in Australia with over 1,000 registered products which are delivered directly through our warehouse. These include key innovation products, prescription and OTC medicines – both branded and generics. Our manufacturing facility in Queensland produces billions of doses of medicine every year.

We are a leading supplier of medicines to the Australian Pharmaceutical Benefits Scheme (PBS) and 43 out of the top 50 PBS products sold by volume are Viatris medicines.